This is in line with the concept that the complement system is difficult to modulate with small molecules, although anti-complement therapies are under investigation for use in AMD [46], in agreement with the findings presented here of increased C3 and C5 in the dry AMD-like mouse model. The gene discussed is C3; the disease is dry age related macular degeneration.